Loading...
Header Logo
Keywords
Last Name
Institution

QIANGHUA HU

TitleInstructor
InstitutionMD Anderson
DepartmentPulmonary Medicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ding S, Tian Y, Cai P, Zhang D, Cheng X, Sun D, Yuan L, Chen J, Tu W, Wei DQ, Hu QN. novoPathFinder: a webserver of designing novel-pathway with integrating GEM-model. Nucleic Acids Res. 2020 Jul 02; 48(W1):W477-W487. PMID: 32313937.
      View in: PubMed
    2. Cho MS, Noh K, Haemmerle M, Li D, Park H, Hu Q, Hisamatsu T, Mitamura T, Mak SLC, Kunapuli S, Ma Q, Sood AK, Afshar-Kharghan V. Role of ADP receptors on platelets in the growth of ovarian cancer. Blood. 2017 09 07; 130(10):1235-1242. PMID: 28679740.
      View in: PubMed
    3. Hu Q, Hisamatsu T, Haemmerle M, Cho MS, Pradeep S, Rupaimoole R, Rodriguez-Aguayo C, Lopez-Berestein G, Wong STC, Sood AK, Afshar-Kharghan V. Role of Platelet-Derived Tgfß1 in the Progression of Ovarian Cancer. Clin Cancer Res. 2017 Sep 15; 23(18):5611-5621. PMID: 28611202.
      View in: PubMed
    4. Maturu P, Jones D, Ruteshouser EC, Hu Q, Reynolds JM, Hicks J, Putluri N, Ekmekcioglu S, Grimm EA, Dong C, Overwijk WW. Role of Cyclooxygenase-2 Pathway in Creating an Immunosuppressive Microenvironment and in Initiation and Progression of Wilms' Tumor. Neoplasia. 2017 03; 19(3):237-249. PMID: 28254151.
      View in: PubMed
    5. Jeter CR, Liu B, Lu Y, Chao HP, Zhang D, Liu X, Chen X, Li Q, Rycaj K, Calhoun-Davis T, Yan L, Hu Q, Wang J, Shen J, Liu S, Tang DG. NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis. Cell Discov. 2016; 2:16041. PMID: 27867534.
      View in: PubMed
    6. Cho MS, Rupaimoole R, Choi HJ, Noh K, Chen J, Hu Q, Sood AK, Afshar-Kharghan V. Complement Component 3 Is Regulated by TWIST1 and Mediates Epithelial-Mesenchymal Transition. J Immunol. 2016 Feb 01; 196(3):1412-8. PMID: 26718342.
      View in: PubMed
    7. Zhao H, Shen J, Hu Q, Davis W, Medico L, Wang D, Yan L, Guo Y, Liu B, Qin M, Nesline M, Zhu Q, Yao S, Ambrosone CB, Liu S. Effects of preanalytic variables on circulating microRNAs in whole blood. Cancer Epidemiol Biomarkers Prev. 2014 Dec; 23(12):2643-8. PMID: 25472672.
      View in: PubMed
    8. Shen J, Hu Q, Schrauder M, Yan L, Wang D, Medico L, Guo Y, Yao S, Zhu Q, Liu B, Qin M, Beckmann MW, Fasching PA, Strick R, Johnson CS, Ambrosone CB, Zhao H, Liu S. Circulating miR-148b and miR-133a as biomarkers for breast cancer detection. Oncotarget. 2014 Jul 30; 5(14):5284-94. PMID: 25051376.
      View in: PubMed
    9. Shukrun R, Pode-Shakked N, Pleniceanu O, Omer D, Vax E, Peer E, Pri-Chen S, Jacob J, Hu Q, Harari-Steinberg O, Huff V, Dekel B. Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk. Stem Cell Reports. 2014 Jul 08; 3(1):24-33. PMID: 25068119.
      View in: PubMed
    10. Flores LG, Yeh HH, Soghomonyan S, Young D, Bankson J, Hu Q, Alauddin M, Huff V, Gelovani JG. Monitoring therapy with MEK inhibitor U0126 in a novel Wilms tumor model in Wt1 knockout Igf2 transgenic mice using 18F-FDG PET with dual-contrast enhanced CT and MRI: early metabolic response without inhibition of tumor growth. Mol Imaging Biol. 2013 Apr; 15(2):175-85. PMID: 22875335.
      View in: PubMed
    11. Hu Q, Gao F, Tian W, Ruteshouser EC, Wang Y, Lazar A, Stewart J, Strong LC, Behringer RR, Huff V. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. J Clin Invest. 2011 Jan; 121(1):174-83. PMID: 21123950.
      View in: PubMed
    12. Luo R, Lu JF, Hu Q, Maity SN. CBF/NF-Y controls endoplasmic reticulum stress induced transcription through recruitment of both ATF6(N) and TBP. J Cell Biochem. 2008 Aug 01; 104(5):1708-23. PMID: 18348279.
      View in: PubMed
    13. Hu Q, Lu JF, Luo R, Sen S, Maity SN. Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle. Nucleic Acids Res. 2006; 34(21):6272-85. PMID: 17098936.
      View in: PubMed
    14. Wang YL, Liang YZ, Chen BM, He YK, Li BY, Hu QN. LC-DAD-APCI-MS-based screening and analysis of the absorption and metabolite components in plasma from a rabbit administered an oral solution of danggui. Anal Bioanal Chem. 2005 Sep; 383(2):247-54. PMID: 16132135.
      View in: PubMed
    15. Hu QN, Liang YZ, Wang YL, Xu CJ, Zeng ZD, Fang KT, Peng XL, Hong Y. External factor variable connectivity index. J Chem Inf Comput Sci. 2003 May-Jun; 43(3):773-8. PMID: 12767135.
      View in: PubMed
    16. Hu Q, Bhattacharya C, Maity SN. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase IIalpha. Conventional CBF activation domains are not required. J Biol Chem. 2002 Oct 04; 277(40):37191-200. PMID: 12149265.
      View in: PubMed
    17. Coustry F, Hu Q, de Crombrugghe B, Maity SN. CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure. J Biol Chem. 2001 Nov 02; 276(44):40621-30. PMID: 11514576.
      View in: PubMed
    18. Hu Q, Maity SN. Stable expression of a dominant negative mutant of CCAAT binding factor/NF-Y in mouse fibroblast cells resulting in retardation of cell growth and inhibition of transcription of various cellular genes. J Biol Chem. 2000 Feb 11; 275(6):4435-44. PMID: 10660616.
      View in: PubMed
    19. Hu Q, Henney HR. An Acanthamoeba polyubiquitin gene and application of its promoter to the establishment of a transient transfection system. Biochim Biophys Acta. 1997 Mar 20; 1351(1-2):126-36. PMID: 9116025.
      View in: PubMed
    20. Complement component 3 is regulated by TWIST1 and mediates epithelial-mesenchymal transition. Journal of Immunology. 196:1412-1418.
    21. Lipid profile of platelets and platelet-derived microparticles in ovarian cancer. BBA Clinical. 6:76-81.
    22. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation. Neoplasia (United States). 18:71-81.
    23. A small amount of cyclooxygenase 2 (COX2) is constitutively expressed in platelets. Platelets. 1-4.
    24. Role of Cyclooxygenase-2 Pathway in Creating an Immunosuppressive Microenvironment and in Initiation and Progression of Wilms' Tumor. Neoplasia (United States).
    HU's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description